Inflammasome activation seem to play an important role in systemic Juvenile Idiopathic Arthritis (SJIA) pathophysiology, characterized by high levels of IL-18 and IL-1 pathway activation. This evidence concerns the gene IL18 and systemic-onset juvenile idiopathic arthritis.